SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibitionPeter Mullen, Heather R. Christofk|Nature Communications|2021Cited by 152
Sensitivity to pertuzumab (2C4) in ovarian cancer models: cross-talk with estrogen receptor signalingPeter Mullen, Simon P. Langdon|Molecular Cancer Therapeutics|2007Cited by 55
Abstract 1855: NUC-1031 overcomes resistance associated with gemcitabine in cancer patientsJennifer Bré, David J. Harrison, Peter Mullen et al.|Cancer Research|2018Cited by 2